ArticleTherapeutic innovation & regulatory science2026

Critical to Quality Assessment Methodology: An Adaptable Clinical Trial Risk Management and Quality Assurance Approach for Quality Functions in Pharmaceutical Companies, Developed by the Inter-Company IMPALA Consortium.

Kiernan Trevett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.